Status:
RECRUITING
Effects of Intermittent Fasting and Exercise on Inflammation, Metabolism, and the Microbiome in Metabolic Syndrome
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Metabolic Syndrome
Obesity and Obesity-related Medical Conditions
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this intervention trial is to assess the effects of intermittent fasting, both alone and in combination with high-intensity interval training, on patients with obesity and metabolic syndro...
Eligibility Criteria
Inclusion
- Written consent to participate in the study.
- Persons aged 18 years and older.
- Diagnosis of Metabolic Syndrome (MetS) with elevated hsCRP.
Exclusion
- Pregnant or nursing individuals.
- Cardiovascular diseases or orthopedic restrictions that prevent exercise.
- Use of medication or supplements that significantly affect study outcomes (e.g., anti-inflammatory medications, antibiotics within the last 6 weeks).
- Body weight greater than 200 kg (maximum capacity of training equipment).
- Individuals with mental illnesses that may impair their ability to understand or participate in the study.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06885255
Start Date
June 1 2023
End Date
March 1 2026
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hector-Center for Nutrition, Exercise and Sports, University Hospital Erlangen
Erlangen, Bavaria, Germany, 91054